Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BioMed Central
'Shock and kill' research gives new hope for HIV-1 eradication
June 15th, 2009
Latent HIV genes can be 'smoked out' of human cells. The so-called 'shock and kill' technique, described in a preclinical study in BioMed Central's open access journal Retrovirology, might represent a new milestone along the way to the discovery of a cure for HIV/AIDS. Dr. Enrico Garaci, president of the Istituto Superiore di Sanita (the Italian Institute of Health) and Dr. Andrea Savarino, a retrovirologist working at the institution, worked with a team of researchers to study the so-called "barrier of latency" which has been the main obstacle to HIV eradication from the body. Cells harbouring a quiescent HIV genome are responsible for HIV...
Source: Biotech Business Week (2009-06-15)
|
